Condition
AChR-Ab Seropositive Generalized Myasthenia Gravis clinical trials and research
As of November 12, 2026, Find a Trial lists 4 AChR-Ab Seropositive Generalized Myasthenia Gravis clinical trials that are recruiting, at sites in 9 countries (most in United States (4), Belgium (3), Greece (3)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 9Countries
Newest AChR-Ab Seropositive Generalized Myasthenia Gravis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| MG patient registry to track long-term experiences and treatment patterns | — | Framingham, Massachusetts | Recruiting | Aug 12, 2026 |
| Empasiprubart IV in people with AChR-Ab positive generalized myasthenia gravis | Phase 2 | Carlsbad, California and 13 other locations | Recruiting | Jun 29, 2026 |
| ADAPT Forward master protocol testing multiple regimens for generalized myasthenia gravis | — | Carlsbad, California and 36 other locations | Recruiting | Dec 19, 2025 |
| Adding empasiprubart to efgartigimod for AChR-antibody positive generalized myasthenia gravis | Phase 2 | Carlsbad, California and 32 other locations | Recruiting | Dec 16, 2025 |
All recruiting trials (4)
-
MG patient registry to track long-term experiences and treatment patterns
This registry collects information from adults with myasthenia gravis to see how symptoms and quality of life change over time and how treatments relate to those changes.
-
Empasiprubart IV in people with AChR-Ab positive generalized myasthenia gravis
This study tests whether empasiprubart given by IV can help people with AChR-Ab positive generalized myasthenia gravis feel better and have fewer symptoms.
-
ADAPT Forward master protocol testing multiple regimens for generalized myasthenia gravis
This platform tests several drug regimens, including efgartigimod IV and empasiprubart IV, in adults with generalized myasthenia gravis to find safer and more effective treatment combinations.
-
Adding empasiprubart to efgartigimod for AChR-antibody positive generalized myasthenia gravis
This trial will test whether adding empasiprubart to efgartigimod infusions helps people with AChR-antibody positive generalized myasthenia gravis who have only had a partial response to efgartigimod.
Related topics
Quick answers
How many AChR-Ab Seropositive Generalized Myasthenia Gravis clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in United States (4 trials), Belgium (3 trials), Greece (3 trials), Japan (3 trials), Spain (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.